Intermediates for spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and
-3'-pyrrolidine] compounds
    62.
    发明授权
    Intermediates for spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'-pyrrolidine] compounds 失效
    螺[2H-1,4-苯并二氧杂环庚烷-3(5H)4'-哌啶和-3'-吡咯烷]化合物的中间体

    公开(公告)号:US4569998A

    公开(公告)日:1986-02-11

    申请号:US630135

    申请日:1984-07-12

    IPC分类号: C07D211/48 C07D491/10

    CPC分类号: C07D491/10 C07D211/48

    摘要: Spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'-pyrrolidine] compounds of the formula ##STR1## where the substituents are as defined herein, are useful in the treatment of hypertension in mammals. Such compounds, their use as antihypertensive agents, pharmaceutical compositions containing the compounds, intermediates and processes for preparing the compounds are provided.

    摘要翻译: 其中取代基如本文所定义的式[IMAGE]的螺[2H-1,4-苯并二氧杂环庚烷-3(5H)4'-哌啶和-3'-吡咯烷]化合物可用于治疗哺乳动物的高血压。 提供这样的化合物,它们作为抗高血压药的用途,含有化合物的药物组合物,中间体和制备化合物的方法。

    Pyrrolylaminopiperidines, compositions thereof and methods of use
    63.
    发明授权
    Pyrrolylaminopiperidines, compositions thereof and methods of use 失效
    吡咯基氨基哌啶,其组合物和使用方法

    公开(公告)号:US4546105A

    公开(公告)日:1985-10-08

    申请号:US647309

    申请日:1984-09-04

    CPC分类号: C07D401/12 C07D409/14

    摘要: This invention relates to pyrrolylaminopiperidines and related compounds of the formula ##STR1## where R is hydrogen, loweralkyl, Arloweralkyl, cycloalkylloweralkyl, loweralkenyl and thienylloweralkyl; R.sub.1 loweralkyl, hydrogen, loweralkylcarbonyl, loweralkoxycarbonyl, loweralkylthiocarbonyl of the formula ##STR2## cyano, loweralkylaminocarbonyl, diloweralkylaminocarbonyl, cycloalkylcarbonyl, cycloalkylloweralkylcarbonyl and loweralkenylcarbonyl; R.sub.2 is hydrogen, halogen and methyl; and the pharmaceutically acceptable acid addition salts thereof.

    摘要翻译: 本发明涉及吡咯并氨基哌啶及其相关化合物,其中R是氢,低级烷基,低级烷基,环烷基低级烷基,低级烯基和噻吩基低级烷基; R 1低级烷基,氢,低级烷基羰基,低级烷氧基羰基,低级烷硫基羰基,氰基,低级烷基氨基羰基,二低级烷基氨基羰基,环烷基羰基,环烷基低级烷基羰基和低级烯基羰基。 R2是氢,卤素和甲基; 及其药学上可接受的酸加成盐。

    3-(4-Piperidinyl)-1,2-benzisothiazoles
    65.
    发明授权
    3-(4-Piperidinyl)-1,2-benzisothiazoles 失效
    3-(4-哌啶基)-1,2-苯并异噻唑

    公开(公告)号:US4524074A

    公开(公告)日:1985-06-18

    申请号:US602780

    申请日:1984-04-23

    CPC分类号: C07D417/04 C07D417/14

    摘要: Novel 3-(4-piperidinyl)-1,2-benzisothiazoles, processes for the preparation thereof, and method of treating psychoses and alleviating pain employing compounds or compositions thereof are disclosed.

    摘要翻译: 公开了新型3-(4-哌啶基)-1,2-苯并异噻唑,其制备方法,以及使用化合物或其组合物治疗精神病和缓解疼痛的方法。

    4-Aryloxy-1,2,3,4-tetrahydroisoquinolines
    67.
    发明授权
    4-Aryloxy-1,2,3,4-tetrahydroisoquinolines 失效
    4-芳氧基-1,2,3,4-四氢异喹啉

    公开(公告)号:US4477670A

    公开(公告)日:1984-10-16

    申请号:US451139

    申请日:1982-12-20

    IPC分类号: C07D217/24 A61K31/47

    CPC分类号: C07D217/24

    摘要: This invention relates to 4-aryloxy-1,2,3,4-tetrahydroisoquinolines of the formula ##STR1## where Y is hydrogen and alkoxy; X is hydrogen, cyano, benzoyl, trifluoromethyl, phenyl, halogen, alkyl alkoxy and nitro; R is hydrogen and alkyl; R.sub.1 is hydrogen, alkyl, aralkyl, ##STR2## and Co.sub.2 R.sub.4 where R.sub.4 is aryl and alkyl; R.sub.2 and R.sub.3 are the same or different and are hydrogen and alkyl or R.sub.2 and R.sub.3 are fused together to form a pyrrolidino or a piperidino ring substituent; and m is an integer of 1 or 2; n is an integer of 2 or 3; and a pharmaceutically acceptable acid addition salt thereof.

    摘要翻译: 本发明涉及式为“IMAGE”的4-芳氧基-1,2,3,4-四氢异喹啉,其中Y为氢和烷氧基; X是氢,氰基,苯甲酰基,三氟甲基,苯基,卤素,烷基烷氧基和硝基; R是氢和烷基; R 1是氢,烷基,芳烷基,和C 2 R 4,其中R 4是芳基和烷基; R2和R3相同或不同,为氢和烷基或R2和R3稠合在一起形成吡咯烷子基或哌啶子基环取代基; m为1或2的整数; n为2或3的整数; 及其药学上可接受的酸加成盐。

    Substituted 4,10-dihydro-10-oxothieno benzoxepins
    68.
    发明授权
    Substituted 4,10-dihydro-10-oxothieno benzoxepins 失效
    取代的4,10-二氢-10-氧代噻吩并苯并氧杂苯环酮

    公开(公告)号:US4477465A

    公开(公告)日:1984-10-16

    申请号:US474218

    申请日:1983-03-10

    IPC分类号: C07D495/04 A61K31/38

    CPC分类号: C07D495/04

    摘要: This invention relates to substituted 4,10-dihydro-10-oxothieno benzoxepins of the formula, ##STR1## where R is hydrogen and lower alkyl; R.sub.1 is ##STR2## where R.sub.2 is hydrogen, lower alkyl and benzyl of the formula ##STR3## where X is hydrogen, lower alkyl, lower alkoxy, halogen, trifluoromethyl, nitro, and amino; ##STR4## where R.sub.3 and R.sub.4 are the same or different and are hydrogen and lower alkyl; ##STR5## where R.sub.5 and R.sub.6 are the same or different and are lower alkyl; and the pharmaceutically acceptable acid addition salts thereof.

    摘要翻译: 本发明涉及下式的取代的4,10-二氢-10-氧代噻吩并苯并恶庚质,其中R是氢和低级烷基; R 1是其中R 2是氢,低级烷基和下式的苄基,其中X是氢,低级烷基,低级烷氧基,卤素,三氟甲基,硝基和氨基; 其中R3和R4相同或不同,为氢和低级烷基; 其中R 5和R 6相同或不同,为低级烷基; 及其药学上可接受的酸加成盐。

    Pyrrolylaminopiperidines
    69.
    发明授权
    Pyrrolylaminopiperidines 失效
    吡咯烷基氨基哌啶

    公开(公告)号:US4452803A

    公开(公告)日:1984-06-05

    申请号:US533677

    申请日:1983-09-19

    CPC分类号: C07D401/12 C07D409/14

    摘要: This invention relates to pyrrolylaminopiperidines and related compounds of the formula ##STR1## where R is hydrogen, loweralkyl, Arloweralkyl, cycloalkylloweralkyl, loweralkenyl and thienylloweralkyl; R.sub.1 is lower alkyl, hydrogen, loweralkylcarbonyl, loweralkoxycarbonyl, loweralkylthiocarbonyl of the formula ##STR2## cyano, loweralkylaminocarbonyl, diloweralkylaminocarbonyl, cycloalkylcarbonyl, cycloalkylloweralkylcarbonyl and loweralkenylcarbonyl; R.sub.2 is hydrogen, halogen and methyl; and the pharmaceutically acceptable acid addition salts thereof.

    摘要翻译: 本发明涉及吡咯并氨基哌啶及其相关化合物,其中R是氢,低级烷基,低级烷基,环烷基低级烷基,低级烯基和噻吩基低级烷基; R 1是下式的低级烷基,氢,低级烷基羰基,低级烷氧基羰基,氰基低级烷硫基羰基,低级烷基氨基羰基,二低级烷基氨基羰基,环烷基羰基,环烷基低级烷基羰基和低级烯基羰基。 R2是氢,卤素和甲基; 及其药学上可接受的酸加成盐。